High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer

被引:42
作者
Chen, Li [1 ,2 ]
Yang, Liu [1 ,2 ]
Qiao, Feng [1 ]
Hu, Xin [1 ]
Li, Shan [1 ]
Yao, Ling [1 ]
Yang, Xue-Li [3 ]
Shao, Zhi-Ming [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Dalian Med Univ, Dept Canc Stem Cell, Dalian, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 10期
基金
中国国家自然科学基金;
关键词
SUBTYPES; NUSAP; IDENTIFICATION; RISK;
D O I
10.1371/journal.pone.0140572
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Nucleolar spindle-associated protein (NuSAP1) is an important mitosis-related protein, and aberrant NuSAP1 expression is associated with abnormal spindles and mitosis. This study investigated the prognostic value of NuSAP1 in breast cancer. Methods Two sets of tissue microarrays (TMAs) that included samples from 450 breast cancer patients were constructed, of which 250 patients were training set and the other 200 patients were validation set. Immunohistochemical staining was performed to determine the NuSAP1 levels. A Kaplan-Meier analysis was used to estimate the prognostic value of NuSAP1 in breast cancer. A stepwise Cox analysis was performed to construct a risk-prediction model for triple-negative breast cancer (TNBC). All statistical analysis was performed with SPSS software. Results There were 108 (43.5%) and 88 (44.0%) patients expressed NuSAP1 in the training set and validation set respectively. High levels of NuSAP1 expression were related to poor diseasefree survival (DFS) in both training (P = 0.028) and validation (P = 0.006) cohorts, particularly in TNBC. With combination of two cohorts, both NuSAP1 (HR = 4.136, 95% CI: 1.9568.747, P < 0.001) and BRCA1 (HR = 0.383, 95% CI: 0.160-0.915, P = 0.031) were independent prognostic indicators of DFS in TNBC. A receiver operating characteristic (ROC) analysis revealed that the combination of NuSAP1 and BRCA1 significantly improved the prognostic power compared with the traditional model (0.778 versus 0.612, P < 0.001). Conclusions Our study confirms the prognostic value of NuSAP1 in breast cancer. The combination of NuSAP1 and BRCA1 could improve the DFS prediction accuracy in TNBC.
引用
收藏
页数:14
相关论文
共 27 条
  • [1] Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma
    Bidkhori, Gholamreza
    Narimani, Zahra
    Ashtiani, Saman Hosseini
    Moeini, Ali
    Nowzari-Dalini, Abbas
    Masoudi-Nejad, Ali
    [J]. PLOS ONE, 2013, 8 (07):
  • [2] Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
    Burstein, Matthew D.
    Tsimelzon, Anna
    Poage, Graham M.
    Coyington, Kyle R.
    Contreras, Alejandro
    Fuqua, Suzanne A. W.
    Sayage, Michelle I.
    Osborne, C. Kent
    Hilsenbeck, Susan G.
    Chang, Jenny C.
    Mills, Gordon B.
    Lau, Ching C.
    Brown, Powel H.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1688 - 1698
  • [3] The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
    Carey, Lisa A.
    Dees, E. Claire
    Sawyer, Lynda
    Gatti, Lisa
    Moore, Dominic T.
    Collichio, Frances
    Ollila, David W.
    Sartor, Carolyn I.
    Graham, Mark L.
    Perou, Charles M.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (08) : 2329 - 2334
  • [4] Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women
    Colak, Dilek
    Nofal, Asmaa
    AlBakheet, AlBandary
    Nirmal, Maimoona
    Jeprel, Hatim
    Eldali, Abdelmoneim
    AL-Tweigeri, Taher
    Tulbah, Asma
    Ajarim, Dahish
    Al Malik, Osama
    Inan, Mehmet S.
    Kaya, Namik
    Park, Ben H.
    Bin Amer, Suad M.
    [J]. PLOS ONE, 2013, 8 (05):
  • [5] Breast cancer in China
    Fan, Lei
    Strasser-Weippl, Kathrin
    Li, Jun-Jie
    St Louis, Jessica
    Finkelstein, Dianne M.
    Yu, Ke-Da
    Chen, Wan-Qing
    Shao, Zhi-Ming
    Goss, Paul E.
    [J]. LANCET ONCOLOGY, 2014, 15 (07) : E279 - E289
  • [6] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch, A.
    Wood, W. C.
    Coates, A. S.
    Gelber, R. D.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1736 - 1747
  • [7] Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features
    Guler, Gulnur
    Himmetoglu, Cigdem
    Jimenez, Rafael E.
    Geyer, Susan M.
    Wang, Wenle P.
    Costinean, Stefan
    Pilarski, Robert T.
    Morrison, Carl
    Suren, Dinc
    Liu, Jianhua
    Chen, Jingchun
    Kamal, Jyoti
    Shapiro, Charles L.
    Huebner, Kay
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 421 - 432
  • [8] Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1
    Gulzar, Z. G.
    McKenney, J. K.
    Brooks, J. D.
    [J]. ONCOGENE, 2013, 32 (01) : 70 - 77
  • [9] Chemotherapy for breast cancer (Review)
    Hassan, M. S. U.
    Ansari, J.
    Spooner, D.
    Hussain, S. A.
    [J]. ONCOLOGY REPORTS, 2010, 24 (05) : 1121 - 1131
  • [10] BRCA1 Pathway Function in Basal-Like Breast Cancer Cells
    Hill, Sarah J.
    Clark, Allison P.
    Silver, Daniel P.
    Livingston, David M.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (20) : 3828 - 3842